Hidetoshi Masumoto

Pluripotent stem cell-engineered cell sheets reassembled with defined cardiovascular populations ameliorate reduction in infarct heart function through cardiomyocyte-mediated neovascularization.

Cardiovascular surgery for realization of regenerative medicine.

Prevention of retrosternal adhesion by novel biocompatible glue derived from food additives.

Effects of hepatocyte growth factor in myocarditis rats induced by immunization with porcine cardiac myosin.

Effect of microRNA-145 to prevent vein graft disease in rabbits by regulation of smooth muscle cell phenotype.

Human iPS cell-engineered cardiac tissue sheets with cardiomyocytes and vascular cells for cardiac regeneration.

Efficient long-term survival of cell grafts after myocardial infarction with thick viable cardiac tissue entirely from pluripotent stem cells.

Green Tea Polyphenol Prevents Diabetic Rats From Acute Kidney Injury After Cardiopulmonary Bypass.

The myocardial regenerative potential of three-dimensional engineered cardiac tissues composed of multiple human iPS cell-derived cardiovascular cell lineages.

Prevention of abdominal aortic aneurysm progression by oral administration of green tea polyphenol in a rat model.

Human iPS Cell-Derived Cardiac Tissue Sheets: a Platform for Cardiac Regeneration.

Fetal mesenchymal stem cells ameliorate acute lung injury in a rat cardiopulmonary bypass model.

Untiring steps toward the maturation of human stem cell-engineered heart tissue.

Efficient and robust differentiation of endothelial cells from human induced pluripotent stem cells via lineage control with VEGF and cyclic AMP.

Impact of Cell Composition and Geometry on Human Induced Pluripotent Stem Cells-Derived Engineered Cardiac Tissue.

Recombinant human soluble thrombomodulin prevents acute lung injury in a rat cardiopulmonary bypass model.

Modelling Torsade de Pointes arrhythmias in vitro in 3D human iPS cell-engineered heart tissue.

Therapeutic angiogenesis by local sustained release of microRNA-126 using poly lactic-co-glycolic acid nanoparticles in murine hindlimb ischemia.

Identification of Cardiomyocyte-Fated Progenitors from Human-Induced Pluripotent Stem Cells Marked with CD82.

A therapeutic angiogenesis of sustained release of basic fibroblast growth factor using biodegradable gelatin hydrogel sheets in a canine chronic myocardial infarction model.

Sustained release of basic fibroblast growth factor using gelatin hydrogel improved left ventricular function through the alteration of collagen subtype in a rat chronic myocardial infarction model.

Human iPS cell-derived cardiac tissue sheets for functional restoration of infarcted porcine hearts.

Human iPS cell-engineered three-dimensional cardiac tissues perfused by capillary networks between host and graft.

MicroRNA-145-loaded poly(lactic-co-glycolic acid) nanoparticles attenuate venous intimal hyperplasia in a rabbit model.

Chronic optical pacing conditioning of h-iPSC engineered cardiac tissues.

Basic fibroblast growth factor attenuates left-ventricular remodeling following surgical ventricular restoration in a rat ischemic cardiomyopathy model.

The N-terminal lectin-like domain of thrombomodulin reduces acute lung injury without anticoagulant effects in a rat cardiopulmonary bypass model.

Management of retrosternal adhesion after median sternotomy by controlling degradation speed of a dextran and ε-poly (L-lysine)-based biocompatible glue.